ArticleThe Journal of biological chemistry2018

Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.

Peng Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.